Valtierra Oba Elva R, Anguiano Morán Ana C, Calderón Cortes Elizabeth, Valtierra Oba Myriam I, Lemus Loeza Barbara M, Rodríguez-Orozco Alain Raimundo
Nursing, Universidad Michoacana de San Nicolás de Hidalgo, Morelia, MEX.
Geriatrics, Universidad Michoacana de San Nicolás de Hidalgo, Morelia, MEX.
Cureus. 2024 Aug 29;16(8):e68156. doi: 10.7759/cureus.68156. eCollection 2024 Aug.
Irritable bowel syndrome (IBS) is a fairly common functional digestive disorder; it occurs at any age but it is more common in adults and older adults. Patients experience a series of symptoms in which abdominal pain and changes in bowel movements stand out; some studies have revealed a possible association between IBS and psychological problems, such as anxiety and depression. Recent findings point to disorders of gut-brain interaction, disruption and alteration of gut microbiota and dysbiosis as key factors in the etiopathogenesis of IBS; aging is also one the factors involved. Most patients diagnosed with IBS required pharmacotherapy, greater caution needs to be considered when treating older patients because of the risk-benefit profile in the elderly. In this scenario, probiotics and non-pharmacological treatments appear as safe and accessible options. Clinicians must take into consideration the unique biopsychosocial factors in older adults when treating IBS. We aim to review critically recent literature on the topic of IBS as there is a need for consolidated guidelines.
肠易激综合征(IBS)是一种相当常见的功能性消化紊乱疾病;它在任何年龄均可发生,但在成年人和老年人中更为常见。患者会出现一系列症状,其中腹痛和排便习惯改变较为突出;一些研究表明,IBS与焦虑和抑郁等心理问题之间可能存在关联。最近的研究结果指出,肠-脑相互作用紊乱、肠道微生物群的破坏和改变以及生态失调是IBS发病机制中的关键因素;衰老也是其中一个相关因素。大多数被诊断为IBS的患者需要药物治疗,由于老年人的风险效益情况,在治疗老年患者时需要更加谨慎。在这种情况下,益生菌和非药物治疗似乎是安全且可及的选择。临床医生在治疗IBS时必须考虑老年人独特的生物心理社会因素。鉴于需要统一的指南,我们旨在对近期关于IBS这一主题的文献进行批判性综述。